---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-017186"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2023-05-03T23:59:59+00:00"
generated_at: "2026-06-16T00:55:46.181010+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Outset Medical Q1 revenue $33.5M (+9.5% YoY); raises FY2023 revenue and margin guidance

## Summary
- Revenue $33.5M, up 9.5% YoY; product revenue $27.8M (+8.2%), service revenue $5.7M (+16.4%).
- Gross margin 19.2% (20.3% non-GAAP), up from 14.5% a year ago; product margin 25.1% vs 10.0%.
- Net loss ($44.0M) or ($0.90) per share; non-GAAP net loss ($35.4M) or ($0.72) per share.
- FY2023 revenue guidance raised to $144-$150M (prior $140-$150M); gross margin guidance raised to low-20% (from ~20%).
- Added over 30 new hospital sites in Q1, largest quarterly new site growth since 2021; cash $252.5M.

## SEC filing metadata
- accession: 0000950170-23-017186
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2023-05-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000095017023017186/0000950170-23-017186-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000095017023017186/om-20230503.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-017186
- JSON: https://secwatch.observer/filing/0000950170-23-017186.json
- Plain text: https://secwatch.observer/filing/0000950170-23-017186.txt

## Key facts
- Earnings Releases
  Outset Medical, Inc. reported first quarter ended March 31, 2023 results: revenue $33.5 million, net income ($44.0) million, EPS ($0.90) per share. Guidance raised.
  - Period: first quarter ended March 31, 2023
  - Revenue: $33.5 million
  - Net income: ($44.0) million
  - EPS: ($0.90) per share
  - Guidance: raised
  - Result: reported results
  source text: to reduce the cost and complexity of dialysis, today reported financial results for the first quarter ended March 31, 2023. Recent Highlights • Recorded net revenue of $33.5 million in the first quarter, a 9.5% increase compared to $30.6 million in the first quarter of 2022, and a 4.6% increase compared to $32.0 million in the fourth quarter of 2022 •
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000095017023017186/0000950170-23-017186-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.